Manhattan Bridge Capital (LOAN) Competitors $5.39 +0.09 (+1.70%) Closing price 04:00 PM EasternExtended Trading$5.34 -0.05 (-0.93%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LOAN vs. BZAI, BIOX, TCI, APPS, IPXX, NREF, SJT, PINE, OACC, and KVACShould you be buying Manhattan Bridge Capital stock or one of its competitors? The main competitors of Manhattan Bridge Capital include Blaize (BZAI), Bioceres Crop Solutions (BIOX), Transcontinental Realty Investors (TCI), Digital Turbine (APPS), Inflection Point Acquisition Corp. II (IPXX), NexPoint Real Estate Finance (NREF), San Juan Basin Royalty Trust (SJT), Alpine Income Property Trust (PINE), Oaktree Acquisition Corp. III Life Sciences (OACC), and Keen Vision Acquisition (KVAC). These companies are all part of the "trading" industry. Manhattan Bridge Capital vs. Blaize Bioceres Crop Solutions Transcontinental Realty Investors Digital Turbine Inflection Point Acquisition Corp. II NexPoint Real Estate Finance San Juan Basin Royalty Trust Alpine Income Property Trust Oaktree Acquisition Corp. III Life Sciences Keen Vision Acquisition Manhattan Bridge Capital (NASDAQ:LOAN) and Blaize (NASDAQ:BZAI) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation, community ranking and profitability. Do analysts rate LOAN or BZAI? Blaize has a consensus target price of $7.25, suggesting a potential upside of 164.60%. Given Blaize's stronger consensus rating and higher probable upside, analysts clearly believe Blaize is more favorable than Manhattan Bridge Capital.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Manhattan Bridge Capital 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Blaize 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has more volatility & risk, LOAN or BZAI? Manhattan Bridge Capital has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500. Comparatively, Blaize has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Which has stronger earnings and valuation, LOAN or BZAI? Manhattan Bridge Capital has higher revenue and earnings than Blaize. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioManhattan Bridge Capital$7.37M8.24$5.48M$0.4811.05Blaize$1.55M179.12N/AN/AN/A Is LOAN or BZAI more profitable? Manhattan Bridge Capital has a net margin of 56.93% compared to Blaize's net margin of 0.00%. Manhattan Bridge Capital's return on equity of 13.06% beat Blaize's return on equity.Company Net Margins Return on Equity Return on Assets Manhattan Bridge Capital56.93% 13.06% 7.75% Blaize N/A N/A N/A Does the MarketBeat Community believe in LOAN or BZAI? Manhattan Bridge Capital received 222 more outperform votes than Blaize when rated by MarketBeat users. However, 100.00% of users gave Blaize an outperform vote while only 76.53% of users gave Manhattan Bridge Capital an outperform vote. CompanyUnderperformOutperformManhattan Bridge CapitalOutperform Votes22576.53% Underperform Votes6923.47% BlaizeOutperform Votes3100.00% Underperform VotesNo Votes Does the media favor LOAN or BZAI? In the previous week, Manhattan Bridge Capital had 6 more articles in the media than Blaize. MarketBeat recorded 6 mentions for Manhattan Bridge Capital and 0 mentions for Blaize. Blaize's average media sentiment score of 0.45 beat Manhattan Bridge Capital's score of 0.33 indicating that Blaize is being referred to more favorably in the news media. Company Overall Sentiment Manhattan Bridge Capital Neutral Blaize Neutral Do insiders & institutionals have more ownership in LOAN or BZAI? 21.8% of Manhattan Bridge Capital shares are owned by institutional investors. Comparatively, 97.1% of Blaize shares are owned by institutional investors. 24.5% of Manhattan Bridge Capital shares are owned by insiders. Comparatively, 68.5% of Blaize shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryBlaize beats Manhattan Bridge Capital on 9 of the 16 factors compared between the two stocks. Remove Ads Get Manhattan Bridge Capital News Delivered to You Automatically Sign up to receive the latest news and ratings for LOAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOAN vs. The Competition Export to ExcelMetricManhattan Bridge CapitalReal estate investment trusts IndustryFinance SectorNASDAQ ExchangeMarket Cap$60.68M$6.81B$10.86B$7.37BDividend Yield9.35%7.51%6.01%4.31%P/E Ratio10.8357.9521.7117.78Price / Sales8.246.5825.4394.74Price / Cash11.5917.3217.6134.64Price / Book1.411.632.513.98Net Income$5.48M$177.71M$1.03B$247.33M7 Day Performance7.83%3.79%2.77%4.31%1 Month Performance-7.00%-8.24%-3.69%-7.80%1 Year Performance5.25%5.82%534.75%1.40% Manhattan Bridge Capital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOANManhattan Bridge Capital1.5137 of 5 stars$5.39+1.7%N/A+5.0%$61.66M$7.37M11.006Upcoming EarningsAnalyst ForecastShort Interest ↑News CoverageGap UpBZAIBlaizeN/A$2.51+12.6%$10.00+298.4%N/A$254.99M$1.55M0.00N/ABIOXBioceres Crop Solutions1.9183 of 5 stars$3.97-3.9%$9.88+148.7%-65.9%$248.96M$407.73M198.60500Short Interest ↑TCITranscontinental Realty Investors1.6123 of 5 stars$28.53+1.2%N/A-14.2%$246.47M$44.76M77.11N/AAnalyst ForecastPositive NewsAPPSDigital Turbine1.6452 of 5 stars$2.28-3.0%$2.38+4.2%+59.8%$239.42M$483.58M-0.75840Gap DownIPXXInflection Point Acquisition Corp. IIN/A$7.55+16.2%N/A+28.6%$235.94MN/A0.00N/AGap UpHigh Trading VolumeNREFNexPoint Real Estate Finance3.6035 of 5 stars$13.26-6.7%$14.50+9.4%+4.7%$233.94M$29.20M12.631Positive NewsHigh Trading VolumeSJTSan Juan Basin Royalty Trust1.4975 of 5 stars$4.90-1.8%N/A+11.6%$228.38M$6.95M18.152,020News CoveragePositive NewsHigh Trading VolumePINEAlpine Income Property Trust2.7312 of 5 stars$15.52-4.7%$19.14+23.3%+10.8%$228.04M$52.23M110.86N/AUpcoming EarningsShort Interest ↑Positive NewsOACCOaktree Acquisition Corp. III Life SciencesN/A$10.16-0.1%N/AN/A$227.84MN/A0.00N/APositive NewsKVACKeen Vision AcquisitionN/A$11.26+0.4%N/A+7.1%$218.06MN/A0.00N/AShort Interest ↓Positive News Remove Ads Related Companies and Tools Related Companies BZAI Alternatives BIOX Alternatives TCI Alternatives APPS Alternatives IPXX Alternatives NREF Alternatives SJT Alternatives PINE Alternatives OACC Alternatives KVAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOAN) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Manhattan Bridge Capital, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Manhattan Bridge Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.